1.47
Fate Therapeutics Inc Borsa (FATE) Ultime notizie
Why Fate Therapeutics Inc. stock remains a top recommendationGDP Growth & Technical Entry and Exit Alerts - newser.com
How Fate Therapeutics Inc. stock benefits from global expansionStop Loss & Short-Term High Return Strategies - newser.com
Analyzing drawdowns of Fate Therapeutics Inc. with statistical toolsAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
Is Fate Therapeutics Inc a good long term investmentInstitutional Holding Changes & Secret Picks Wall Street Isn’t Talking About - earlytimes.in
Using fundamentals and technicals on Fate Therapeutics Inc.Earnings Beat & Daily Market Momentum Tracking - newser.com
Is Fate Therapeutics Inc. stock reversal real or fakeMarket Movement Recap & Step-by-Step Trade Execution Guides - newser.com
Is Fate Therapeutics Inc. stock affected by interest rate hikesJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com
Published on: 2025-10-14 21:30:26 - newser.com
FATE appoints Kamal Adawi CFO as board reduces from 10 to 8 - Stock Titan
Fate Therapeutics, Inc. Appoints Kamal Adawi as Chief Financial Officer, Effective October 20, 2025 - MarketScreener
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer - GlobeNewswire
375,000-option grant leads Fate Therapeutics' appointment of Kamal Adawi as CFO, effective Oct 20, 2025 - Stock Titan
Automated trading signals detected on Fate Therapeutics Inc.Trade Exit Summary & Reliable Price Breakout Alerts - newser.com
Advanced analytics toolkit walkthrough for Fate Therapeutics Inc.Options Play & Community Driven Trade Alerts - newser.com
Published on: 2025-10-13 07:01:23 - newser.com
What technical signals suggest for Fate Therapeutics Inc. stockJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
What’s next for Fate Therapeutics Inc. stock priceWeekly Earnings Recap & High Win Rate Trade Alerts - newser.com
Risk vs reward if holding onto Fate Therapeutics Inc.July 2025 Review & Free Safe Capital Growth Stock Tips - newser.com
Historical volatility pattern of Fate Therapeutics Inc. visualizedEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Real time social sentiment graph for Fate Therapeutics Inc.Trade Volume Report & Verified Entry Point Signals - newser.com
Fate Therapeutics (NASDAQ:FATE) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat
Fate Therapeutics, Inc. $FATE Stock Holdings Lessened by Public Employees Retirement System of Ohio - Defense World
Fate Therapeutics (NASDAQ:FATE) Stock Price Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat
Is Fate Therapeutics Inc. stock in correction or buying zoneJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
Chart based analysis of Fate Therapeutics Inc. trendsMarket Activity Report & Real-Time Market Trend Scan - newser.com
Fate Therapeutics Inc. stock daily chart insightsPortfolio Performance Report & Weekly Breakout Stock Alerts - newser.com
What analysts say about Fate Therapeutics Inc stockPrice Gap Trading Strategies & Big Returns, Small Investment – Learn How - earlytimes.in
Detecting price anomalies in Fate Therapeutics Inc. with AI2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Is Fate Therapeutics Inc. stock trading at a premium valuationFed Meeting & Real-Time Buy Signal Alerts - newser.com
Fate Therapeutics, Inc. (NASDAQ:FATE) institutional owners may be pleased with recent gains after 62% loss over the past year - Yahoo Finance
Fate Therapeutics Reports New Employee Inducement Awards under Nasdaq Listing Rule 5635(4) - MarketScreener
Should you hold or exit Fate Therapeutics Inc. now2025 Market Sentiment & Reliable Intraday Trade Alerts - newser.com
Top chart patterns to watch in Fate Therapeutics Inc.July 2025 Price Swings & High Return Trade Guides - newser.com
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Fate Therapeutics reports new employee inducement awards under Nasdaq listing rule - MarketScreener
Great week for Fate Therapeutics, Inc. (NASDAQ:FATE) institutional investors after losing 62% over the previous year - simplywall.st
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):